[{"address1": "245 Main Street", "address2": "Second Floor", "city": "Cambridge", "state": "MA", "zip": "02142", "country": "United States", "phone": "617 500 8080", "website": "https://immuneering.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Immuneering Corporation, a clinical-stage oncology company, engages in the development of medicines for broad populations of cancer patients. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor currently under Phase 1/2a clinical trial to treat patients with cancer, including pancreatic, melanoma, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 that is in Phase 1/2a clinical trial for the treatment of patients with solid tumors. Immuneering Corporation was incorporated in 2008 and is based in Cambridge, Massachusetts.", "fullTimeEmployees": 54, "companyOfficers": [{"maxAge": 1, "name": "Dr. Benjamin J. Zeskind M.B.A., Ph.D.", "age": 42, "title": "Co-Founder, President, CEO & Director", "yearBorn": 1982, "fiscalYear": 2024, "totalPay": 941316, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert J. Carpenter M.B.A., M.S.", "age": 78, "title": "Co-Founder & Chair Emeritus", "yearBorn": 1946, "fiscalYear": 2024, "totalPay": 45000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Brett M. Hall Ph.D.", "age": 56, "title": "Chief Scientific Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 918124, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Michael D. Bookman J.D.", "age": 37, "title": "Chief Legal Officer & Secretary", "yearBorn": 1987, "fiscalYear": 2024, "totalPay": 689959, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Leah R. Neufeld", "age": 52, "title": "Chief People Officer", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Peter  King Ph.D.", "title": "Head of Discovery & VP", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Praveen  Nair Ph.D.", "title": "Head of Translational Pharmacology & VP", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Harold E. Brakewood", "age": 58, "title": "Chief Business Officer", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 579769, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Igor  Matushansky M.D., Ph.D.", "age": 51, "title": "Chief Medical Officer", "yearBorn": 1973, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 6, "compensationRisk": 8, "shareHolderRightsRisk": 7, "overallRisk": 7, "governanceEpochDate": 1754006400, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.63, "open": 4.69, "dayLow": 4.5027, "dayHigh": 4.98, "regularMarketPreviousClose": 4.63, "regularMarketOpen": 4.69, "regularMarketDayLow": 4.5027, "regularMarketDayHigh": 4.98, "payoutRatio": 0.0, "beta": 0.37, "forwardPE": -2.9817073, "volume": 1252604, "regularMarketVolume": 1252604, "averageVolume": 1392862, "averageVolume10days": 1114740, "averageDailyVolume10Day": 1114740, "bid": 4.83, "ask": 5.84, "bidSize": 1, "askSize": 2, "marketCap": 177599424, "fiftyTwoWeekLow": 1.06, "fiftyTwoWeekHigh": 4.98, "fiftyDayAverage": 3.531, "twoHundredDayAverage": 2.201375, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 155244368, "profitMargins": 0.0, "floatShares": 27538425, "sharesOutstanding": 36318900, "sharesShort": 1555893, "sharesShortPriorMonth": 1724555, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.0432, "heldPercentInsiders": 0.24124001, "heldPercentInstitutions": 0.10574, "shortRatio": 2.09, "shortPercentOfFloat": 0.056599997, "impliedSharesOutstanding": 36318900, "bookValue": 0.804, "priceToBook": 6.0820894, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -62128864, "trailingEps": -1.9, "forwardEps": -1.64, "enterpriseToEbitda": -2.437, "52WeekChange": 3.1794872, "SandP52WeekChange": 0.1513431, "quoteType": "EQUITY", "currentPrice": 4.89, "targetHighPrice": 21.0, "targetLowPrice": 8.0, "targetMeanPrice": 12.8, "targetMedianPrice": 12.0, "recommendationMean": 1.4, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 26355498, "totalCashPerShare": 0.726, "ebitda": -63700328, "totalDebt": 4000560, "quickRatio": 3.52, "currentRatio": 3.703, "debtToEquity": 13.826, "returnOnAssets": -0.68372, "returnOnEquity": -1.3046601, "freeCashflow": -29878488, "operatingCashflow": -51509300, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "IMRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "cryptoTradeable": false, "regularMarketChangePercent": 5.61555, "regularMarketPrice": 4.89, "postMarketChangePercent": 0.20450367, "postMarketPrice": 4.9, "postMarketChange": 0.010000229, "regularMarketChange": 0.26, "regularMarketDayRange": "4.5027 - 4.98", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 1392862, "fiftyTwoWeekLowChange": 3.83, "fiftyTwoWeekLowChangePercent": 3.6132076, "fiftyTwoWeekRange": "1.06 - 4.98", "fiftyTwoWeekHighChange": -0.09000015, "fiftyTwoWeekHighChangePercent": -0.01807232, "fiftyTwoWeekChangePercent": 317.94873, "earningsTimestampStart": 1763064000, "earningsTimestampEnd": 1763064000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.9, "epsForward": -1.64, "epsCurrentYear": -1.65, "priceEpsCurrentYear": -2.9636364, "fiftyDayAverageChange": 1.359, "fiftyDayAverageChangePercent": 0.38487682, "twoHundredDayAverageChange": 2.6886249, "twoHundredDayAverageChangePercent": 1.2213389, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-07-30", "averageAnalystRating": "1.4 - Strong Buy", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1627651800000, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1755906565, "regularMarketTime": 1755892801, "exchange": "NGM", "messageBoardId": "finmb_308350677", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Immuneering Corporation", "longName": "Immuneering Corporation", "displayName": "Immuneering", "trailingPegRatio": null, "__fetch_time": "2025-08-23"}]